reverse listing maybe easier, there was a run of those on the Nasdaq for a few ears after 2011 but if they could pull that off, then get FDA approvals or vise versa a significant re-rate wld occur you'd think
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.01 |
Change
-0.390(2.53%) |
Mkt cap ! $321.3M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.20 | $15.01 | $45.58K | 3.011K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 243 | 1 |
View Market Depth
| Last trade - 12.06pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |